Happiness Biotech Group Stock Forecast, Price & News

Wall Street analysts have given Happiness Biotech Group a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Happiness Biotech Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Happiness Biotech Group's stock was trading at $3.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, HAPP shares have decreased by 57.6% and is now trading at $1.62.
View which stocks have been most impacted by COVID-19.

Happiness Biotech Group announced a -- dividend on Friday, July 31st. Investors of record on Monday, August 10th will be paid a dividend of $0.015 per share on Monday, August 17th. The ex-dividend date of this dividend is Friday, August 7th.
View Happiness Biotech Group's dividend history.

Some companies that are related to Happiness Biotech Group include MediWound (MDWD), Natural Alternatives International (NAII), Mannatech (MTEX), FitLife Brands (FTLF), Nutra Pharma (NPHC), Glucose Health (GLUC), Tauriga Sciences (TAUG), Cyanotech (CYAN), Heyu Biological Technology (HYBT), GLG Life Tech (GLGLF), Exactus (EXDI), Entia Biosciences (ERGO), Rock Creek Pharmaceuticals (RCPIQ), Beleave (BE) and Beleave (BE).
View all of HAPP's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Happiness Biotech Group investors own include Aytu Biopharma (AYTU), Heat Biologics (HTBX), AIM ImmunoTech (AIM), Tonix Pharmaceuticals (TNXP), Gilead Sciences (GILD), iBio (IBIO), BOQI International Medical (BIMI), Bionano Genomics (BNGO), Check-Cap (CHEK) and (COCP).

(HAPP) raised $11 million in an initial public offering (IPO) on Friday, October 25th 2019. The company issued 2,000,000 shares at $5.50 per share. Univest Securities served as the underwriter for the IPO and WestPark Capital, Newbridge Securities and Zivest Global were co-managers.

Happiness Biotech Group trades on the NASDAQ under the ticker symbol "HAPP."

Happiness Biotech Group's stock is owned by many different retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (3.71%), HRT Financial LP (0.35%), Citadel Advisors LLC (0.12%) and Citadel Advisors LLC (0.12%).

HAPP stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, and Citadel Advisors LLC.

HAPP stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, and HRT Financial LP.

Shares of HAPP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HAPP stock can currently be purchased for approximately $1.62.

Happiness Biotech Group has a market capitalization of $41.96 million and generates $65.06 million in revenue each year.

Happiness Biotech Group employs 151 workers across the globe.

The official website for Happiness Biotech Group is www.happ.org.cn.

Happiness Biotech Group is headquartered at NO. 11 DONGJIAO EAST ROAD SHUANGXI SHUNCHANG, NANPING F4, 353001.

Happiness Biotech Group's mailing address is NO. 11 DONGJIAO EAST ROAD SHUANGXI SHUNCHANG, NANPING F4, 353001. The company can be reached via phone at 86-059-9782-8808 or via email at [email protected]